化疗对乳腺癌患者甲状腺功能或结构的影响

基础医学与临床 ›› 2020, Vol. 40 ›› Issue (5): 688-691.

化疗对乳腺癌患者甲状腺功能或结构的影响

刘杨, 朱悦, 姚景昊, 刘静, 周争光, 赵福友, 杨燕^*

蚌埠医学院第一附属医院肿瘤内科, 安徽蚌埠 233004

收稿日期:2019-08-29 修回日期:2019-12-03 出版日期:2020-05-05 发布日期:2020-04-30
通讯作者: *qiannianhupo@163.com
基金资助:
安徽省“十三五”医疗卫生重点培育专科建设项目(见皖卫科教〔2017〕30号文件);蚌埠医学院第一附属医院 2018年度领先新技术项目(2018126)

Effect of chemotherapy on thyroid function or structure in patients with breast cancer

LIU Yang, ZHU Yue, YAO Jing-hao, LIU Jing, ZHOU Zheng-guang, ZHAO Fu-you, YANG Yan^*

Department of Medical Oncology, the First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China

Received:2019-08-29 Revised:2019-12-03 Online:2020-05-05 Published:2020-04-30
Contact: *qiannianhupo@163.com

摘要/Abstract

摘要： 目的探讨化疗对乳腺癌患者甲状腺功能或结构的近期影响。方法选取蚌埠医学院第一附属医院于2017年3月至2018年12月收治的40例女性初治原发性乳腺癌患者,检测并比较化疗后2和4疗程与化疗前的甲状腺功能5项(包括T3、T4、FT3、FT4和TSH)及其结构的变化。结果乳腺癌患者化疗2和4疗程后T4、FT4水平明显低于化疗前(P＜0.05);患者化疗4疗程后甲状腺TI-RADS分级及其结构异常的发生率较化疗前均明显升高(P＜0.05)。结论化疗后近期可引起或加重乳腺癌患者甲状腺功能或结构的异常,适时进行检查并干预可防止病情进一步发展,具有重要的临床意义。

关键词: 乳腺癌, 化疗, 甲状腺功能, 甲状腺结构

Abstract: Objective To investigate the short-term effect of chemotherapy on thyroid function or structure in patients with breast cancer. Methods Forty female patients with primary breast cancer treated in the first affiliated Hospital of Bengbu Medical College from March 2017 to December 2018 were selected. The changes of thyroid function (including T3, T4, FT3, FT4 and TSH) and their structure were measured and compared between before and after chemotherapy for two and four cycles. Results The levels of T4 and FT4 were significantly lower in breast cancer patients receiving either two or four cycles of chemotherapy than those receiving no chemotherapy(P＜0.05); and the levels of thyroid TI-RADS grade and the incidence of abnormal thyroid structure were significantly higher in patients receiving four courses of chemotherapy than those receiving no chemotherapy (P＜0.05). Conclusions In the near future,the event of chemotherapy can cause or aggravate abnormal thyroid function or structure in patients with breast cancer. Regular physical examination and necessary intervention have important clinical significance to prevent the development of thyroid disease.

Key words: breast cancer, chemotherapy, thyroid function, thyroid structure

中图分类号:

R737.9

刘杨, 朱悦, 姚景昊, 刘静, 周争光, 赵福友, 杨燕. 化疗对乳腺癌患者甲状腺功能或结构的影响[J]. 基础医学与临床, 2020, 40(5): 688-691.

LIU Yang, ZHU Yue, YAO Jing-hao, LIU Jing, ZHOU Zheng-guang, ZHAO Fu-you, YANG Yan. Effect of chemotherapy on thyroid function or structure in patients with breast cancer[J]. Basic & Clinical Medicine, 2020, 40(5): 688-691.

参考文献

[1]Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65:87-108.
[2]Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012[J]. Eur J Cancer,2013, 49:1374-1403.
[3]Hardefeldt PJ, Eslick GD, Edirimanne S. Benign thyroid disease is associated with breast cancer: a meta-analysis[J]. Breast Cancer Res Treat, 2012, 133:1169-1177.
[4]Smyth PP. The thyroid and breast cancer[J]. Curr Opin Endocrinol Diabetes Obes, 2016, 23:389-393.
[5]高明,郑向前. 甲状腺癌过去与未来十年[J]. 中国肿瘤临床,2018, 45:2-6.
[6]黄剑波, 金梁斌, 孔令泉, 等. 乳腺癌患者治疗期间甲状腺功能的变化研究[J]. 重庆医科大学学报, 2014, 38:57-60.
[7]Khan MA, Bhurani D, Agarwal NB. Alteration of thyroid function in indian HER 2-negative breast cancer patients undergoing chemotherapy[J]. Asian Pac J Cancer Prev, 2015, 16:7701-7705.
[8]Shi Y, Li X, Ran L, et al. Study on the status of thyroid function and thyroid nodules in chinese breast cancer patients[J].Oncotarget, 2017, 8:80820-80825.
[9]刘倩欣, 向倩, 张卓, 等. 乳腺癌患者化疗药物不良反应情况及影响因素分析[J]. 中国临床药理学杂志, 2018, 34:475-478.
[10]Li Y, Jiang D, Wu YY, et al. A multicenter clinical study for the comparison of S-1 versus capecitabine in the treatment of advanced breast cancer[J]. 中华肿瘤杂志, 2017, 39:607-612.
[11]Ortega-Olvera C, Ulloa-Aguirre A, Angeles-Llerenas A, et al. Thyroid hormones and breast cancer association according to menopausal status and body mass index[J]. Breast Cancer Res, 2018, 20:94-107.
[12]Dong L, Lu J, Zhao B, et al. Review of the possible association between thyroid and breast carcinoma[J]. World J Surg Oncol, 2018, 16:130-136.

[1]	王子辕, 段昭君, 罗云萍. 小鼠乳腺癌肺特异性转移细胞亚系的建立和验证[J]. 基础医学与临床, 2022, 42(7): 1083-1091.
[2]	韩雪莹, 崔丰, 李隽. 乳腺癌缺失因子1(DBC1)影响乳腺癌细胞系对依托泊苷的敏感性[J]. 基础医学与临床, 2022, 42(7): 1060-1066.
[3]	康有力, 赵丹, 杜文静, 李莉. SIRT5通过调控ALDH5A1的琥珀酰化促进人乳腺癌细胞的增殖[J]. 基础医学与临床, 2022, 42(7): 1099-1107.
[4]	谢利华, 杨奇, 李雅倩, 谢心悦, 雷诗娟, 周琳. 转录因子Kaiso下调人乳腺癌细胞系中lncRNA MEG3的表达[J]. 基础医学与临床, 2022, 42(5): 758-762.
[5]	何啸, 胡为杰, 吕文昌, 任玉萍, 吴敏, 吴毅平, 张奇. 环状RNA在乳腺癌中作用的研究进展[J]. 基础医学与临床, 2022, 42(3): 507-511.
[6]	张妍, 朱孟雯, 刘桐, 杨圣, 梁戈玉. N6-甲基腺苷(m6A)RNA修饰在生殖系统疾病中作用的研究进展[J]. 基础医学与临床, 2021, 41(9): 1347-1351.
[7]	熊玉圆, 陈德杰, 孟琳, 晏珊. TLK2促进人乳腺癌细胞系增殖、迁移和侵袭[J]. 基础医学与临床, 2021, 41(8): 1156-1162.
[8]	王海燕, 黄明全, 潘广锐, 汪贵林, 梁斌, 权毅. 低氧微环境促进人乳腺癌细胞系MCF-7的侵袭和增殖[J]. 基础医学与临床, 2021, 41(4): 539-544.
[9]	郑亚男, 李梅, 赵基源. 乳腺癌骨转移分子机制及靶向药物的研究进展[J]. 基础医学与临床, 2021, 41(3): 433-437.
[10]	张天瑞, 高文怡, 姚娟. KDM3A沉默对人乳腺癌细胞系MDA-MB-231凋亡和侵袭能力的影响[J]. 基础医学与临床, 2021, 41(1): 33-37.
[11]	阳德全, 李常有, 崔军威, 韦伟, 王少平. hsa-miR-4483促进人乳腺癌细胞系的增殖和迁移[J]. 基础医学与临床, 2020, 40(9): 1230-1236.
[12]	胡庆庆, 鲁兖. 吲哚胺2,3-双加氧酶1抑制剂Epacadostat联合γ干扰素诱导三阴乳腺癌细胞系凋亡[J]. 基础医学与临床, 2020, 40(5): 615-620.
[13]	秦岭, 邢泽宇, 刘嘉琦, 钱天一, 王畅畅, 王昕, 王翔. 50例中国男性乳腺癌临床特征和遗传学病因[J]. 基础医学与临床, 2020, 40(5): 684-687.
[14]	郑文艺, 吴裕明, 郝轶. 超声靶向微泡破坏技术及其在乳腺癌治疗方面的应用[J]. 基础医学与临床, 2020, 40(4): 552-556.
[15]	张良, 刘明永, 刘鹏, 薛鑫, 张良民, 郭乔楠, 赵建华. 骨肉瘤细胞脱逸化疗诱导的细胞衰老可重新增殖成瘤细胞[J]. 基础医学与临床, 2020, 40(2): 187-191.